Federal contractor · BOCA RATON, FL

AVENTUSOFT L.L.C

No contract obligations recorded for AVENTUSOFT L.L.C in FY2026. It also received $2.2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
LX1DCB3LCT87
Small businessMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 150KFY2017

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for AVENTUSOFT L.L.C in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

AVENTUSOFT L.L.C received $2.2M in federal assistance in FY2026, on 7 actions (2 new awards), +27% vs FY2025. Its largest program was 93.837 · Cardiovascular Diseases Research ($1.7M).

Assistance · FY2026
$2.2M
New awards
2
Actions
7
Since FY2021
$10.1M

Assistance by fiscal year

  1. 3.4MFY2021
  2. 1.5MFY2022
  3. 474.8KFY2023
  4. 864.8KFY2024
  5. 1.7MFY2025
  6. 2.2MFY2026

By type

  1. Grants$2.2M100%

Top programs

  1. 93.837 · Cardiovascular Diseases Research$1.7M77%
  2. 93.866 · Aging Research$500K23%

Awarding agencies

  1. National Institutes of Health$2.2M100%
    Department of Health and Human Services

Largest awards

  1. NON-INVASIVE CLOUD CONNECTED DEVICE FOR HEMODYNAMIC-GUIDED THERAPY TOIMPROVE OUTCOMES FOR HEART FAILURE PATIENTS$4.5M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Nov 27, 2020 – Jul 22, 2026· R44HL145941
  2. A NOVEL NON-INVASIVE DEVICE FOR SCREENING AND OPTIMIZED MANAGEMENT TO IMPROVE HEART FAILURE OUTCOMES IN PATIENTS WITH DIABETES MELLITUS$3.7M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Feb 1, 2021 – Feb 10, 2026· R44HL149561
  3. COMMERCIALIZATION READINESS PILOT PROGRAM SUPPORT FOR: HEMOLINK - 7. PROJECT SUMMARY/ABSTRACT CARDIOVASCULAR DISEASE REMAINS THE LEADING…$500K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Aug 17, 2026 – Sep 28, 2026· SB1HL184385
  4. A SMART REMOTE MONITORING SYSTEM FOR CARDIOMETABOLIC MANAGEMENT IN PATIENTS WITH ALZHEIMER'S AND RELATED DEMENTIA - PROJECT…$500K
    93.866 · Aging Research· National Institutes of Health· Project grant· Sep 17, 2026 – Sep 17, 2026· R43AG099700
  5. AN INNOVATIVE AI-POWERED WEARABLE PHYSIOLOGICAL SENSOR SYSTEM FOR REAL-TIME PAIN MONITORING AND MANAGEMENT (PAINVITALS) - PROJECT…$349.9K
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 5, 2025 – Jun 12, 2026· R41GM162038

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.